Attachment II - Page 2 
9202-013* (T) 
9202-014 (M) 
9202-015 (M) 
9202-016* (T) 
9202-017 b (M) 
9206-018 (T) 
9206-019 (T) 
9206-020* (M) 
9206-021 (T) 
9206-022* (T) 
9206-023* (M) 
9206-024* (M) 
9206-025* (M) 
Nabel, Gary J., University of Michigan, Ann Arbor, Michigan; Immunotherapy of Malignancy by In Vivo Gene Transfer into 
Tumors. 
RAC Approval: 2-10-92/N1H Approval: 4-17-92 
Minor Modification: 1-22-93 
Minor Modification: 1-93 
Cometta, Kenneth, Indiana University, Indianapolis, Indiana; Retroviral-Mediated Gene Transfer of Bone Marrow Cells during 
Autologous Bone Marrow Transplantation for Acute Leukemia. 
RAC Approval: 2-11-92/NIH Approval: 4-17-92 
Economou, James S. and Belldegrun, Aric, University of California at Lx* Angeles, Lo6 Angeles, California; The Treatment of 
Patients with Metastatic Melanoma and Renal Cell Cancer Using In Vitro Expanded and Genetically-Engineered (Neomycin 
Phosphotransferase ) Bulk. CDS (+) and/or CD4(+) Tumor Infiltrating Lymphocytes and Bulk, CD8(+) and/or CD4(+ ) Peripheral 
Blood Leukocytes in Combination with Recombinant Interleukin-2 Alone, or with Recombinant Interleukin-2 and Recombinant Alpha 
Interferon. 
RAC Approval: 2-11-92/NIH Approval: 4-17-92 
Freeman, Scott M., Tulane University Medical Center, New Orleans, Louisiana; Gene Transfer for the Treatment of Cancer. 
RAC Approval: 2-10-92/NIH Approval: 2-5-93 
Minor Modification: 8-6-93 
Greenberg, Philip D. and Riddell, Stanley, Fred Hutchinson Cancer Research Center, University of Washington, Seattle; 
Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy using Genetically Modified CD8+ HIV-Specific T Cells in 
HIV Seropositive Individuals. 
RAC Approval: 2-11-92/NIH Approval: 4-17-92 
Major Amendment/RAC Approval: 9-9-93 
Major Amendment/NIH Approval: 10-7-93 
Brenner, Malcolm K.; Furman, Wayne; Santana, Victor; Bowman, Laura; and Meyer, William, St Jude Children’s Research 
Hospital, Memphis, Tennessee; Phase I Study of Cytokine-Gene Modified Autologous Neuroblastoma Cells for Treatment of 
Relapsed/Refractory Neuroblastoma. 
RAC Approval: 6-1-92/NIH Approval: 8-14-92 
Oldfield, Edward, National Institutes of Health, Bethesda, Maryland; Gene Therapy for the Treatment of Brain Tumors Using 
Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. 
RAC Approval: 6-1-92/NIH Approval: 8-14-92 
Minor Modification: 11-29-93 
Deisseroth, Albert B., MD Anderson Cancer Center, Houston, Texas; Use of Two Retroviral Markers to Test Relative 
Contribution of Marrow and Peripheral Blood Autologous Cells to Recovery After Preparative Therapy. 
RAC Approval: 6-2-92/NIH Approval: 8-14-92 
Minor Modification: 4-19-93 
Gansbacher, Bemd; Houghton, Alan; and Livingston, Philip, Memorial Sloan Kettering Cancer Center, New York, New York; 
Immunization with HLA-A2 matched Allogeneic Melanoma Cells that Secrete Interleukin-2 in Patients with Metastatic Melanoma. 
RAC Approval: 6-2-92/NIH Approval: 8-14-92 
Gansbacher, Bemd; Motzer, Robert; Houghton, Alan; and Bander, Neil, Memorial Sloan Kettering Cancer Center, New York, 
New York; Immunization with Interleukin-2 Secreting Allogeneic HLA-A2 Matched Renal Cell Carcinoma Cells in Patients with 
Advanced Renal Cell Carcinoma. 
RAC Approval: 6-2-92/NIH Approval: 8-14-92 
Minor Modification: 3-31-93 
Dunbar, Cynthia, National Institutes of Health, Bethesda, Maryland; Retroviral-Mediated Gene Transfer of Bone Marrow and 
Peripheral Blood Stem Cells During Autologous Bone Marrow Transplantation for Multiple Myeloma. 
RAC Approval: 6-2-92/NIH Approval: 8-14-92 
Dunbar, Cynthia, National Institutes of Health, Bethesda, Maryland; Retroviral-Mediated Gene Transfer of Bone Marrow and 
Peripheral Blood Stem Cells During Autologous Bone Marrow Transplantation for Metastatic Breast Cancer. 
RAC Approval: 6-2-92/NIH Approval: 8-14-92 
Dunbar, Cynthia, National Institutes of Health, Bethesda, Maryland; Retroviral-Mediated Gene Transfer of Bone Marrow and 
Peripheral Blood Stem Cells During Autologous Bone Marrow Transplantation for Chronic Myelogenous Leukemia. 
RAC Approval: 6-2-92/NIH Approval: 8-14-92 
[574] 
Recombinant DNA Research, Volume 18 
